1.0880
-0.0215
(-1.94%)
As of 8:03:45 AM GMT+2. Market Open.
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 10 | 10 | 14 | 13 |
| Avg. Estimate | 786.1k | 1.29M | 10.83M | 7.01M |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | 2.5M | 5M | 42M | 25M |
| Year Ago Sales | 1.14M | 513k | 32.31M | 10.83M |
| Sales Growth (year/est) | -30.74% | 150.70% | -66.47% | -35.34% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| 8EM.F | -- | -- | -- | -- |
| S&P 500 | 6.76% | 5.73% | 9.19% | 14.14% |
Upgrades & Downgrades
| Maintains | Evercore ISI Group: Outperform to Outperform | 12/16/2024 |
| Downgrade | JP Morgan: Neutral to Underweight | 12/16/2024 |
| Maintains | RBC Capital: Sector Perform to Sector Perform | 12/13/2024 |
| Maintains | Barclays: Equal-Weight to Equal-Weight | 12/13/2024 |
| Downgrade | Chardan Capital: Buy to Neutral | 12/13/2024 |
| Maintains | Baird: Outperform to Outperform | 12/13/2024 |
Related Tickers
1FW2.F WuXi Biologics (Cayman) Inc.
2.2410
-7.95%
0K4.F Akero Therapeutics, Inc.
32.93
+0.09%
IVA.PA Inventiva S.A.
2.8600
+0.70%
22UA.DE BioNTech SE
87.75
-0.34%
NVCT Nuvectis Pharma, Inc.
9.53
-2.56%
IMAB I-Mab
0.9072
-5.07%
FGEN FibroGen, Inc.
0.2962
-1.23%
ATRA Atara Biotherapeutics, Inc.
5.98
+2.22%
ETNB 89bio, Inc.
6.05
+2.20%
OCUL Ocular Therapeutix, Inc.
7.53
-0.53%